Browsing by Issue Date, starting with "2020-10-06"
Now showing 1 - 3 of 3
Results Per Page
Sort Options
- Recomendações para a realização de testes genéticos em cardiologia - revisão das principais diretrizes internacionaisPublication . Sousa, Alexandra; Moldovan, Oana; Lebreiro, Ana; Bourbon, Mafalda; António, Natália; Rato, Quitéria; Rodrigues, Patrícia; Toste, Alexandra; Gonçalves Rocha, Miguel; Oliveira, Renata; Granja, Sofia; Cruz, Cristina; Almeida, Jorge; Martins, ElisabeteNos últimos anos, tem sido crescente o reconhecimento das causas genéticas das doenças cardiovasculares resultado dos significativos progressos das técnicas laboratoriais. Este conhecimento tem permitido a identificação de «novos» fenótipos e a subclassificação das síndromes clínicas, tendo impacto nas decisões terapêuticas e no aconselhamento genético que é facultado às famílias. No presente documento descreve‐se o «estado da arte» relativamente às principais recomendações para testes genéticos nas doenças cardiovasculares, pretendendo‐se providenciar uma ferramenta útil de consulta para cardiologistas e outros profissionais envolvidos na prestação nos cuidados de saúde a doentes com cardiopatias hereditárias e respetivas famílias.
- Phenotypical, Clinical, and Molecular Aspects of Adults and Children With Homozygous Familial Hypercholesterolemia in IberoamericaPublication . Alves, Ana Catarina; Alonso, Rodrigo; Diaz-Diaz, José Luís; Medeiros, Ana Margarida; Jannes, Cinthia E.; Merchan, Alonso; Vasques-Cardenas, Norma A.; Cuevas, Ada; Chacra, Ana Paula; Krieger, Jose E.; Arroyo, Raquel; Arrieta, Francisco; Schreier, Laura; Corral, Pablo; Bañares, Virginia G.; Araujo, Maria B.; Bustos, Paula; Asenjo, Sylvia; Stoll, Mario; Dell'Oca, Nicolás; Reyes, Maria; Ressia, Andrés; Campo, Rafael; Magaña-Torres, Maria T; Metha, Roopa; Aguilar-Salinas, Carlos A; Ceballos-Macias, José J; Morales, Álvaro J Ruiz; Mata, Pedro; Bourbon, Mafalda; Santos, Raul DObjective: Characterize homozygous familial hypercholesterolemia (HoFH) individuals from Iberoamerica. Approach and Results: In a cross-sectional retrospective evaluation 134 individuals with a HoFH phenotype, 71 adults (age 39.3±15.8 years, 38.0% males), and 63 children (age 8.8±4.0 years, 50.8% males) were studied. Genetic characterization was available in 129 (96%). The majority (91%) were true homozygotes (true HoFH, n=79, 43.0% children, 46.8% males) or compound heterozygotes (compound heterozygous familial hypercholesterolemia, n=39, 51.3% children, 46.2% males) with putative pathogenic variants in the LDLR. True HoFH due to LDLR variants had higher total (P=0.015) and LDL (low-density lipoprotein)-cholesterol (P=0.008) compared with compound heterozygous familial hypercholesterolemia. Children with true HoFH (n=34) tended to be diagnosed earlier (P=0.051) and had a greater frequency of xanthomas (P=0.016) than those with compound heterozygous familial hypercholesterolemia (n=20). Previous major cardiovascular events were present in 25 (48%) of 52 children (missing information in 2 cases), and in 43 (67%) of 64 adults with LDLR variants. Children who are true HoFH had higher frequency of major cardiovascular events (P=0.02), coronary heart (P=0.013), and aortic/supra-aortic valve diseases (P=0.022) than compound heterozygous familial hypercholesterolemia. In adults, no differences were observed in major cardiovascular events according to type of LDLR variant. From 118 subjects with LDLR variants, 76 (64%) had 2 likely pathogenic or pathogenic variants. In 89 subjects with 2 LDLR variants, those with at least one null allele were younger (P=0.003) and had a greater frequency of major cardiovascular events (P=0.038) occurring at an earlier age (P=0.001). Conclusions: There was a high frequency of cardiovascular disease even in children. Phenotype and cardiovascular complications were heterogeneous and associated with the type of molecular defect.
- earlyMYCO - Exposição precoce a Micotoxinas e o seu impacto na saúdePublication . Assunção, RicardoSumário: 1. Ambiente (alimentação), Exposição precoce (primeiros 1000 dias de vida) & Developmental Origins of Health and Disease (DOHaD); 2. Alimentação, Contaminantes alimentares (micotoxinas), exposição precoce, intestino (1ª barreira) & consequências para a saúde; 3. Projeto earlyMYCO – Exposição precoce a MICOtoxinas e o seu impacto na saúde.
